文献速递其他结缔组织病

经皮耳迷走神经分支刺激作为系统性硬化症疼痛的非侵入性附加治疗方法

Transcutaneous auricular branch vagal nerve stimulation as a non-invasive add-on therapeutic approach for pain in systemic sclerosis.
PubMed 文献 · RMD Open · 2023-01-01

研究纳入32例系统性硬化症(SSc)患者,其中21例完成随机交叉患者盲试验,比较经皮耳迷走神经刺激(tVNS)与主动对照各4周、间隔4周洗脱的效应。tVNS使疼痛数字评定量表(NRS)评分显著降低(均值±标准差:-27.7%±21.3% vs -7.7%±26.3%,p=0.002),且白介素-6在tVNS较主动对照下调(p=0.029)。tVNS是安全的非侵入性附加工具,可减轻SSc疼痛。

要点

  • tVNS使SSc患者NRS疼痛评分较主动对照显著降低(-27.7%±21.3% vs -7.7%±26.3%,p=0.002)。
  • 白介素-6在tVNS较主动对照下调(p=0.029)。
  • PROMIS-29条目4、生活质量量表及心率变异性在tVNS与主动对照间无显著差异。

核心结论

  • tVNS被证明是减轻SSc疼痛的安全且非侵入性的附加工具。

研究设计与样本

  • 研究纳入32例根据报告疼痛(通过NRS评估)入组的SSc患者,其中21例(90%为局限皮肤型SSc)完成随机、交叉、患者盲试验,干预和主动对照以随机顺序各使用4周,中间间隔4周洗脱。

主要发现

  • NRS疼痛在tVNS组显著降低(均值±标准差:-27.7%±21.3%),主动对照组未显著降低(-7.7%±26.3%),组间p=0.002。
  • 白介素-6在tVNS较主动对照下调(p=0.029)。
  • PROMIS-29条目4、生活质量量表及心率变异性(频谱和符号分析)在tVNS与主动对照间无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Systemic sclerosis (SSc) is an autoimmune disease with health-related quality of life (HRQoL) high impairment. Pain is of paramount importance to be targeted by therapeutical approaches. Our study aim was to perform an add-on device-based non-invasive neuromodulatory treatment through transcutaneous auricular vagal nerve stimulation (tVNS) in patients with SSc, assessing its effects on pain as primary endpoint and on inflammation, cardiovascular autonomic control and HRQoL. METHODS: Thirty-two patients with SSc were enrolled based on reported pain assessed through Numeric Rating Scale (NRS). Twenty-one (90% with limited cutaneous SSc) completed a randomised, cross-over, patient-blind trial, in which interventional and active control were used in random order for 4 weeks, interspersed with 4 weeks washout. NRS, Patient-Reported Outcomes Measurement Information System-29 (PROMIS-29) Item4 for pain interference, heart rate variability (HRV), serum cytokines and HRQoL questionnaires (Health Assessment Questionnaire, Patient Health Questionnaire-9, University of California, Los Angeles Gastrointestinal Tract, Pittsburgh Sleep Quality Index) were assessed at baseline, at T1 (after 1 month of tVNS or active control), at T2 (after washout) and at T3 (after 1 month of active control or tVNS). T-test for paired data and Wilcoxon signed-rank test for non-normally distributed parameters were performed to compare the effect of tVNS and active control. RESULTS: NRS pain was significantly reduced by tVNS and not by active control (Mean±SD: -27.7%±21.3% vs -7.7%±26.3%, p=0.002). Interleukin-6 was downregulated in tVNS versus active control (p=0.029). No significant differences were observed in tVNS versus active control for PROMIS-29 Item4, QoL scales and HRV with both spectral and symbolic analyses. CONCLUSION: tVNS demonstrated to be a safe and non-invasive add-on tool to reduce pain in SSc.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Bellocchi C, Carandina A, Della Torre A, et al. Transcutaneous auricular branch vagal nerve stimulation as a non-invasive add-on therapeutic approach for pain in systemic sclerosis. RMD Open. 2023. PMID: 37536947. doi:10.1136/rmdopen-2023-003265

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。